HealthStream (NASDAQ:HSTM) Announces Quarterly Earnings Results

HealthStream (NASDAQ:HSTM) issued its quarterly earnings results on Monday. The technology company reported $0.19 EPS for the quarter, topping the consensus estimate of $0.13 by $0.06, Briefing.com reports. The firm had revenue of $73.10 million for the quarter, compared to analysts’ expectations of $73.53 million. HealthStream had a net margin of 6.26% and a return on equity of 5.19%. HealthStream’s revenue for the quarter was up 4.0% compared to the same quarter last year. During the same period in the previous year, the business earned $0.13 earnings per share. HealthStream updated its FY 2024 guidance to EPS.

HealthStream Price Performance

Shares of HSTM opened at $28.45 on Tuesday. The company has a market capitalization of $864.82 million, a price-to-earnings ratio of 49.05, a P/E/G ratio of 4.25 and a beta of 0.36. HealthStream has a fifty-two week low of $21.92 and a fifty-two week high of $31.15. The business’s 50-day moving average is $28.63 and its 200-day moving average is $27.84.

Analysts Set New Price Targets

HSTM has been the topic of several recent analyst reports. Canaccord Genuity Group boosted their price objective on HealthStream from $27.00 to $28.00 and gave the stock a “hold” rating in a report on Wednesday, July 24th. StockNews.com downgraded HealthStream from a “strong-buy” rating to a “buy” rating in a report on Wednesday, July 24th. Finally, Craig Hallum upgraded HealthStream to a “strong-buy” rating in a report on Thursday, October 17th. Two equities research analysts have rated the stock with a hold rating, three have given a buy rating and one has given a strong buy rating to the stock. According to MarketBeat, the company currently has an average rating of “Moderate Buy” and an average price target of $30.00.

Insider Activity

In other news, SVP Kevin P. O’hara sold 3,000 shares of the company’s stock in a transaction dated Wednesday, August 7th. The stock was sold at an average price of $28.03, for a total value of $84,090.00. Following the transaction, the senior vice president now owns 9,527 shares in the company, valued at $267,041.81. This represents a 0.00 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. In related news, Director Tate Deborah Taylor sold 1,400 shares of the business’s stock in a transaction that occurred on Thursday, August 29th. The stock was sold at an average price of $28.53, for a total value of $39,942.00. Following the completion of the sale, the director now owns 22,326 shares of the company’s stock, valued at approximately $636,960.78. The trade was a 0.00 % decrease in their position. The sale was disclosed in a filing with the SEC, which can be accessed through this link. Also, SVP Kevin P. O’hara sold 3,000 shares of the business’s stock in a transaction that occurred on Wednesday, August 7th. The shares were sold at an average price of $28.03, for a total value of $84,090.00. Following the completion of the sale, the senior vice president now directly owns 9,527 shares of the company’s stock, valued at approximately $267,041.81. The trade was a 0.00 % decrease in their position. The disclosure for this sale can be found here. 20.60% of the stock is owned by corporate insiders.

HealthStream Company Profile

HealthStream, Inc provides Software-as-a-Service (SaaS) based applications for healthcare organizations in the United States. The company’s solutions help healthcare organizations in meeting their ongoing clinical development, talent management, training, education, assessment, competency management, safety and compliance, and scheduling, as well as provider credentialing, privileging, and enrollment needs.